Mismatch repair deficiency associated with overexpression of the <i>MSH3</i> gene
1998 · Proceedings of the National Academy of Sciences · 210 citations
https://doi.org/10.1073/pnas.95.15.8568
G
Giuseppe Roscilli
Takeda (Italy)(IT)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
77
Papers
2.8K
Citations
30
h-index
44
i10-index
Giuseppe Roscilli is an academic researcher from Takeda (Italy). The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & Immunotherapy and Immune Responses & Virus-based gene therapy research. The author has an h-index of 30, co-authored 66 publications.
ORCID: 0000-0002-0495-8668Papers by this author
worksSARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines
2020 · Journal of Translational Medicine · 197 citations
https://doi.org/10.1186/s12967-020-02392-y
Human lung adenocarcinoma cell cultures derived from malignant pleural effusions as model system to predict patients chemosensitivity
2016 · Journal of Translational Medicine · 53 citations
https://doi.org/10.1186/s12967-016-0816-x
Circulating MMP11 and specific antibody immune response in breast and prostate cancer patients
2014 · Journal of Translational Medicine · 48 citations
https://doi.org/10.1186/1479-5876-12-54
Novel anti‐ErbB3 monoclonal antibodies show therapeutic efficacy in xenografted and spontaneous mouse tumors
2011 · Journal of Cellular Physiology · 32 citations
https://doi.org/10.1002/jcp.24037
A linear DNA encoding the SARS-CoV-2 receptor binding domain elicits potent immune response and neutralizing antibodies in domestic cats
2023 · Molecular Therapy — Methods & Clinical Development · 8 citations
https://doi.org/10.1016/j.omtm.2022.12.015
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat